ETFsXtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C
Xtrackers
Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C
XDG3 LSEAccumulatingIreland
Last close · EUR
38.48EUR
-0.65% · -€0.25
Published closes: 4 Nov 2026 - 5 Nov 2026
5 Nov 2026, close
XDG3Base
- Fund charges
- Not publishedFee basis unverified
- Fund size
- Not published
- Return 1Y
- +24.9%
- Sharpe 3Y
- 0.60
- Volatility 1Y
- 16.4%annualised
- Holdings
- 115Fund holdings
Performance
Compare
- XDG3+24.9%
- Price, EUR
Returns
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|
| XDG3 | +11.7% | +17.7% | +31.2% | +20.3% | +24.9% | +40.5% | - |
| MSCI World | -2.8% | -0.6% | +7.8% | +14.3% | +14.1% | +65.6% | +64.8% |
| Gap to MSCI World | +14.6% | +18.3% | +23.3% | +6.0% | +10.8% | -25.1% | - |
Risk and return
Sharpe ratio · 3Y
0.60
Below MSCI World · 1.24- Return p.a.
- +11.5%
- Volatility
- 15.5%
- Max loss
- -20.5%Apr 2025
Sharpe vs indices
MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
XDG3
0.60
CAC 40
0.37
Method
Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.
Top holdings
- Top 10
- 44.9%
- Holdings
- 115
- As of
- 1THERMO FISHER SCIENTIFICUS88355610234.90%
- 2GILEAD SCIENCESUS37555810364.87%
- 3DANAHERUS23585110284.73%
- 4ABBVIEUS00287Y10914.72%
- 5ELI LILLYUS53245710834.72%
- 6AMGEN INCUS03116210094.61%
- 7JOHNSON & JOHNSONUS47816010464.31%
- 8MERCK & CO INCUS58933Y10554.21%
- 9VERTEX PHARMACEUTICALSUS92532F10033.91%
- 10STRYKERUS86366710133.89%
Countries
Classified 99.9%
United States80.2%
GB
DK
FR
JP
NL
- Largest
- 80.2%United States
- Top 3
- 89.8%
- Effective number
- 1.51 / HHI
Market cap
Weight vs holdings
44.9%of the fund sits in the top 10 holdings
44.9%48.7%
WeightHoldings
104065
- Holdings 1-10
- Holdings 11-50
- Holdings 51-115
Size split
Not published
Compare ETFs in Copio.
Factual research, without a suitability score or investment recommendation. Past relationships can change.
